A RANDOMIZED, PHASE II TRIAL OF KETOCONAZOLE PLUS ALENDRONATE VERSUS KETOCONAZOLE ALONE IN PATIENTS WITH ANDROGEN INDEPENDENT PROSTATE CANCER AND BONE METASTASES-Reference-Cited by-同舟云学术

A RANDOMIZED, PHASE II TRIAL OF KETOCONAZOLE PLUS ALENDRONATE VERSUS KETOCONAZOLE ALONE IN PATIENTS WITH ANDROGEN INDEPENDENT PROSTATE CANCER AND BONE METASTASES

Published:2005-03 Issue:3 Volume:173 Page:790-796
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

FIGG WILLIAM D.¹,LIU YINONG¹,ARLEN PHILIP¹,GULLEY JAMES¹,STEINBERG SETH M.¹,LIEWEHR DAVID J.¹,COX MICHAEL C.¹,ZHAI SUOPING¹,CREMERS SERGE¹,PARR ALLYSON¹,YANG XIAOWEI¹,CHEN CLARA C.¹,JONES ELIZABETH¹,DAHUT WILLIAM L.¹

Affiliation:

1. From the Center for Cancer Research, National Cancer Institute (WDF, YL, PA, JG, SMS, DJL, MCC, SZ, AP, XY, WLD) and Departments of Nuclear Medicine (CCC) and Diagnostic Radiology (EJ), Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland, and Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center (SC), Leiden, The Netherlands

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference26 articles.

1. Cancer Statistics, 2003

2. State-of-the-Art Treatment of Metastatic Hormone-Refractory Prostate Cancer

3. Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group.

4. Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases

5. A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Efficacy of Ketoconazole Containing Regimens in Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis;Clinical Genitourinary Cancer;2024-04

2. Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis;Cochrane Database of Systematic Reviews;2020-12-03

3. Adjuvant and neoadjuvant cancer therapies: A historical review and a rational approach to understand outcomes;Seminars in Oncology;2019-02

4. Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials;World Journal of Urology;2018-12-05

5. Ketoconazole plus Lenalidomide in patients with Castration-Resistant Prostate Cancer (CRPC): results of an open-label phase II study;Investigational New Drugs;2018-09-06